Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2279
Number of pages	1
Journal	New England Journal of Medicine
Volume	393
Issue number	22
DOIs	https://doi.org/10.1056/NEJMc2515262
State	Published - Dec 4 2025

ASJC Scopus subject areas

TY - JOUR

T1 - Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia

AU - Fleischman, Roger A.

PY - 2025/12/4

Y1 - 2025/12/4

UR - https://www.scopus.com/pages/publications/105023912247

UR - https://www.scopus.com/inward/citedby.url?scp=105023912247&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2515262

DO - 10.1056/NEJMc2515262

M3 - Letter

C2 - 41337729

AN - SCOPUS:105023912247

SN - 0028-4793

VL - 393

SP - 2279

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 22

ER -